• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

William T. Curry, MD


  • Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, Louis DN, Rozenblatt-Rosen O, Suvà ML, Regev A, Bernstein BE.Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.Science. 2014 Jun 20(6190):1396-401.
  • Wakimoto H, Tanaka S, Curry WT, Loebel F, Zhao D, Tateishi K, Chen J, Klofas LK, Lelic N, Kim JC, Dias-Santagata D, Ellisen LW, Borger DR, Fendt SM, Vander Heiden MG, Batchelor TT, Iafrate AJ, Cahill DP, Chi AS.Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.Clin Cancer Res. 2014 Jun 1(11):2898-909.
  • Jones PS, Aghi MK, Muzikansky A, Shih HA, Barker FG, Curry WT.Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) database.J Clin Neurosci. 2014 May 19.
  • Jones PS, Aghi MK, Muzikansky A, Shih HA, Barker FG, Curry WT.Outcomes and patterns of care in adult skull base chondrosarcomas from the SEER database.J Clin Neurosci. 2014 Apr 29.
  • Suvà ML, Rheinbay E, Gillespie SM, Patel AP, Wakimoto H, Rabkin SD, Riggi N, Chi AS, Cahill DP, Nahed BV, Curry WT, Martuza RL, Rivera MN, Rossetti N, Kasif S, Beik S, Kadri S, Tirosh I, Wortman I, Shalek AK, Rozenblatt-Rosen O, Regev A, Louis DN, Bernstein BE.Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.Cell. 2014 Apr 24;157(3):580-94.
  • Gray ST, Lin A, Curry WT, Barker FG, Busse P, Sanan A, Deschler DG, Lin DT.Delayed complications after anterior craniofacial resection of malignant skull base tumors.J Neurol Surg B Skull Base. 2014 Apr;75(2):110-6.
  • Herr MW, Sethi RK, Meier JC, Chambers KJ, Remenschneider A, Chan A, Curry WT, Barker FG, Deschler DG, Lin DT.Esthesioneuroblastoma: an update on the massachusetts eye and ear infirmary and massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy.J Neurol Surg B Skull Base. 2014 Feb;75(1):58-64.
  • Herr MW, Gray ST, Erman AB, Curry WT, Deschler DG, Lin DT.Orbital preservation in patients with esthesioneuroblastoma.J Neurol Surg B Skull Base. 2013 Jun;74(3):142-5.
  • Venteicher AS, Walcott BP, Sheth SA, Snuderl M, Patel AP, Curry WT, Nahed BV.Clinical features of brain metastasis from salivary gland tumors.J Clin Neurosci. 2013 Nov;20(11):1533-7.
  • Reardon DA, Wucherpfennig KW, Freeman G, Wu CJ, Chiocca EA, Wen PY, Curry WT, Mitchell DA, Fecci PE, Sampson JH, Dranoff G.An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma.Expert Review Of Vaccines. 2013 Jun;12(6):597-615.
  • Biermann JS, Adkins DR, Agulnik M, Benjamin RS, Brigman B, Butrynski JE, Cheong D, Chow W, Curry WT, Frassica DA, Frassica FJ, Hande KR, Hornicek FJ, Jones RL, Mayerson J, McGarry SV, McGrath B, Morris CD, O'Donnell RJ, Randall RL, Santana VM, Satcher RL, Siegel HJ, von Mehren M, Bergman MA, Sundar H.Bone cancer.J Natl Compr Canc Netw. 2013 Jun 1;11(6):688-723.
  • Hanak BW, Walcott BP, Nahed BV, Muzikansky A, Mian MK, Kimberly WT, Curry WT.Postoperative Intensive Care Unit Requirements After Elective Craniotomy.World Neurosurg. 2012 Nov 24.
  • Jones PS, Dunn GP, Barker FG, Curry WT, Hochberg FH, Cahill DP.Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th Annual Frye-Halloran Brain Tumor Symposium.Neurosurg Focus. 2013 Feb;34(2):E9.
  • Tanaka S, Louis DN, Curry WT, Batchelor TT, Dietrich J.Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?.Nat Rev Clin Oncol. 2013 Jan;10(1):14-26.
  • Chi AS, Batchelor TT, Dias-Santagata D, Borger D, Stiles CD, Wang DL, Curry WT, Wen PY, Ligon KL, Ellisen L, Louis DN, Iafrate AJ.Prospective, high-throughput molecular profiling of human gliomas.J. Neurooncol. 2012 Oct;110(1):89-98.
  • Snuderl M, Wirth D, Sheth SA, Bourne SK, Kwon CS, Ancukiewicz M, Curry WT, Frosch MP, Yaroslavsky AN.Dye-Enhanced Multimodal Confocal Imaging as a Novel Approach to Intraoperative Diagnosis of Brain Tumors.Brain Pathol. 2012 Aug 6.
  • Barnard Z, Wakimoto H, Zaupa C, Patel AP, Klehm J, Martuza RL, Rabkin SD, Curry WT.Expression of FMS-like tyrosine kinase 3 ligand by oncolytic herpes simplex virus type I prolongs survival in mice bearing established syngeneic intracranial malignant glioma.Neurosurgery. 2012 Sep;71(3):741-8; discussion 748.
  • Plotkin SR, O'Donnell CC, Curry WT, Bove CM, Maccollin M, Nunes FP.Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients.J Neurosurg Spine. 2011 Apr;14(4):543-7.
  • Jeyaretna DS, Curry WT, Batchelor TT, Stemmer-Rachamimov A, Plotkin SR.Exacerbation of cerebral radiation necrosis by bevacizumab.J Clin Oncol. 2011 Mar 1;29(7):e159-62.
  • Walcott BP, Jaglowski JR, Curry WT.Spinal epidural metastasis.Arch Neurol. 2010 Mar;67(3):358-9.
  • Curry WT, Carter BS, Barker FG.Racial, ethnic, and socioeconomic disparities in patient outcomes after craniotomy for tumor in adult patients in the United States, 1988-2004.Neurosurgery. 2010 Mar;66(3):427-37; discussion 437-8.
  • Agarwalla PK, Barnard ZR, Curry WT.Virally mediated immunotherapy for brain tumors.Neurosurg Clin N Am. 2010 Jan;21(1):167-79. Review.
  • Truong MT, Kamat UR, Liebsch NJ, Curry WT, Lin DT, Barker FG, Loeffler JS, Chan AW.Proton radiation therapy for primary sphenoid sinus malignancies: treatment outcome and prognostic factors.Head Neck. 2009 Oct;31(10):1297-308.
  • Curry WT Jr,Barker FG 2nd.Racial, ethnic and socioeconomic disparities in the treatment of brain tumors.J Neurooncol. 2009 May;93(1):25-39. Review.
  • Aghi MK,Batchelor TT,Louis DN,Barker FG 2nd,Curry WT Jr.Decreased rate of infection in glioblastoma patients with allelic loss of chromosome 10q.J Neurooncol. 2009 May;93(1):115-20.
  • Wakimoto H,Kesari S,Farrell CJ,Curry WT Jr,Zaupa C,Aghi M,Kuroda T,Stemmer-Rachamimov A,Shah K,Liu TC,Jeyaretna DS,Debasitis J,Pruszak J,Martuza RL,Rabkin SD.Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.Cancer Res. 2009 Apr 15;69(8):3472-81.
  • Nichols AC,Chan AW,Curry WT,Barker FG,Deschler DG,Lin DT.Esthesioneuroblastoma: the massachusetts eye and ear infirmary and massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy.Skull Base. 2008 Sep;18(5):327-37.
  • Aghi MK,Carter BS,Cosgrove GR,Ojemann RG,Amin-Hanjani S,Martuza RL,Curry WT Jr,Barker FG 2nd.Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.Neurosurgery. 2009 Jan;64(1):56-60; discussion 60.
  • Farrell CJ,Zaupa C,Barnard Z,Maley J,Martuza RL,Rabkin SD,Curry WT Jr.Combination immunotherapy for tumors via sequential intratumoral injections of oncolytic herpes simplex virus 1 and immature dendritic cells.Clin Cancer Res. 2008 Dec 1;14(23):7711-6.
  • Skog J,Wurdinger T,van Rijn S,Meijer DH,Gainche L,Sena-Esteves M,Curry WT Jr,Carter BS,Krichevsky AM,Breakefield XO.Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.Nat Cell Biol. 2008 Dec;10(12):1470-6.
  • Aghi MK, Eskandar EN, Carter BS, Curry WT Jr, Barker FG 2nd.Increased prevalence of obesity and obesity-related postoperative complications in male patients with meningiomas.Neurosurgery. 2007 Oct;61(4):754-60; discussion 760-1.
  • Dunn GP, Dunn IF, Curry WT.Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma.Cancer Immun. 2007;7:12. Review.
  • Barnholtz-Sloan JS, Maldonado JL, Williams VL, Curry WT, Rodkey EA, Barker FG 2nd, Sloan AE.Racial/ethnic differences in survival among elderly patients with a primary glioblastoma.J Neurooncol. 2007 Nov;85(2):171-80.
  • Cahill DP, Levine KK, Betensky RA, Codd PJ, Romany CA, Reavie LB, Batchelor TT, Futreal PA, Stratton MR, Curry WT, Iafrate AJ, Louis DN.Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.Clin Cancer Res. 2007 Apr 1;13(7):2038-45.
  • Verhey LJ, Chen CC, Chapman P, Loeffler J, Curry WT.Single-fraction stereotactic radiosurgery for intracranial targets.Neurosurg Clin N Am. 2006 Apr;17(2):79-97.
  • Curry WT, Cosgrove GR, Buchbinder BR, Ojemann RG.Resection of a dominant-hemisphere intraventricular meningioma facilitated by functional magnetic resonance imaging. Case report.Neurosurg Focus. 2001;10(6):E1.
  • Curry WT, Cosgrove GR, Hochberg FH, Loeffler J, Zervas NT.Stereotactic interstitial radiosurgery for cerebral metastases.J Neurosurg. 2005 Oct;103(4):630-5.
  • Curry WT, McDermott MW, Carter BS, Barker FG.Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload.J Neurosurg. 2005 Jun;102(6):977-86.
  • Curry WT, Butler WE, Barker FG.Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002.Neurosurgery. 2005 Jul;57(1):97-108; discussion 97-108.
  • Curry WT, Hoh BL, Amin-Hanjani S, Eskandar EN.Spinal epidural abscess: clinical presentation, management, and outcome.Surg Neurol. 2005 Apr;63(4):364-71; discussion 371.
  • Curry WT, Sethi MK, Ogilvy CS, Carter BS.Factors associated with outcome after hemicraniectomy for large middle cerebral artery territory infarction.Neurosurgery. 2005 Apr;56(4):681-92; discussion 681-92.
  • Barker FG, Curry WT, Carter BS.Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care.Neuro-oncol. 2005 Jan;7(1):49-63.
  • Hoh BL, Curry WT, Carter BS, Ogilvy CS.Computed tomographic demonstrated infarcts after surgical and endovascular treatment of aneurysmal subarachnoid hemorrhage.Acta Neurochir (Wien). 2004 Nov;146(11):1177-83.